Because of this, PT-141 is often used in experimental models exploring peptide-mediated communication between the central nervous system and endocrine pathways
Why does retatrutide outperform here
Bottom line on safety: If someone considers peptide therapy, it should be under medical supervision with pre-treatment screening (baseline GH/IGF-I, metabolic panel, glucose), ongoing monitoring, and sourcing from reputable, traceable suppliers under a lawful framework
Currently, there is much interest in delivering GLP-1 receptor agonists via alternate, non-invasive routes with high bioavailability and least side effects as possible
Research on GLP-1 receptor agonists shows that the central nervous system effects extend beyond appetite suppression